Sexually transmitted disease rapid test STI

COVID-19HSVMycoplasma

The Sexually Transmitted Infection (STI) array is the broadest multiplex cartridge-based STI test on the market simultaneously detecting 7 bacterial, 2 viral and 1 protozoan infection for a comprehensive sexual health profile. Globally, each day over 1 million people are exposed to an STI, many of who will not know they have an infection as many STI’s are asymptomatic whilst some individuals will display similar or overlapping symptoms, therefore co-infections may remain undiagnosed. Designed to offer a complete sexual health profile with an aim of prevention and control, the Vivalytic STI array can be used to diagnose existing infections whilst any identifying co-infections. To find out more about the global economic burden of STIs and the impact of the COVID-19 pandemic on sexual health, download our most recent whitepaper that presents issues such as AMR, the development of super-gonorrhoea, and the challenges faced in a social and public concept due to the COVID-19 pandemic. Comprehensive Sexual Health Profile Detecting 10 bacterial, viral and protozoan infections The STI array has recently received CE marking Sample to answer, cartridge based molecular diagnostics at the point of care. Powered by Randox Biochip Technology Simple and easy to use analyser with a small footprint making it suitable for use in laboratory and non-laboratory settings Convenient 4 step process from sample entry to results. No laboratory training required Vivalytic Workflow Intuitive engineering of Vivalytic ensures the analyser is user friendly. The process of patient sample to result comprises a very simple 4 step workflow.